The third session of the workshop focused on the transformative role of Artificial Intelligence (AI)  in  drug  discovery  and  target  identification.  Dr.  Saravanan  provided  an  in-depth exploration of how AI algorithms are reshaping pharmaceutical research, enabling faster, more cost-effective, and more precise discovery processes.
He highlighted the transition from idea to discovery, explaining how AI tools streamline molecular  modeling,  predictive  analytics,  and  personalized  medicine.  The  session emphasized the potential of AI to bridge innovation with clinical application, making drug development more efficient and patient-centered.

Click here for report